Cell-mediated immunity to human tumors. Abrogation by serum factors and nonspecific effects of oral BCG therapy.
D000230:Adenocarcinoma / Q000276:immunology*; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D002277:Carcinoma / Q000276:immunology*; D002462:Cell Membrane / Q000276:immunology; D002464:Cell Migration Inhibition; D002478:Cells, Cultured; D005770:Gastrointestinal Neoplasms / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D007962:Leukocytes / Q000276:immunology; D008264:Macrophages; D008545:Melanoma / Q000276:immunology*; D009365:Neoplasm Regression, Spontaneous; D014612:Vaccines
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D014612:Vaccines